Clinical Trials Browser

Phase 2 × Leukemia, Hairy Cell × venetoclax × Clear all

NCT06311227 2026-05-13

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell